FeesSafety
Pluang+

U.S. spot Bitcoin ETFs see $528M inflows, marking third straight day of gains.

Market News
22 Oct 2026
Tokenpost
View Source
Bullish
U.S. spot Bitcoin ETFs see $528M inflows, marking third straight day of gains.

U.S. spot Bitcoin ETFs attracted $528.40 million in net inflows on October 21, 2026, a 22.8-fold increase from the previous day, continuing a three-day streak of positive inflows. Eight of the 12 ETFs, including BlackRock's IBIT and Fidelity's FBTC, drew fresh capital, contributing to a cumulative net inflow of $57.96 billion. Total trading volume hit $3.15 billion, with BlackRock's IBIT leading in both inflows and assets under management, which collectively represent about 6.42% of Bitcoin's market cap. This sustained investor interest highlights growing confidence in spot Bitcoin ETFs as a digital asset investment vehicle.

The recent surge in Bitcoin spot ETF inflows reached $528.40 million on October 21, 2026. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Oct 22, 2026 13:02 WIB: out of 50 major cryptocurrencies, 10 rose and 39 fell. Notable movers include BAL (Balancer) with a price of Rp16.297 and a 1-day change of +11.14%, EOS (EOS.IO) at Rp12.649 with +8.13%, and KSM (Kusama) at Rp72.433 with a -6.40% change and a Pluang order activity of 32% Sell / 68% Buy.

More News

Privosegtor shows neuroprotective effects in Phase 2 trial for optic neuritis, reducing nerve damage markers.

Privosegtor shows neuroprotective effects in Phase 2 trial for optic neuritis, reducing nerve damage markers.

Oculis Holding AG announced that Privosegtor, in a Phase 2 ACUITY trial, reduced increases in blood biomarkers linked to nerve damage (NfL and GFAP) in patients with optic neuritis compared to placebo. These biomarker improvements support earlier fin...

Company Fundamentals
Bullish
52 minutes ago
Ipsen raises 2026 sales growth forecast to 23% after strong Q3 performance

Ipsen raises 2026 sales growth forecast to 23% after strong Q3 performance

Ipsen reported a 24.6% sales growth at constant exchange rates for the first nine months of 2026, driven by strong performance in Oncology, Rare Disease, and Neuroscience segments. The company upgraded its full-year sales growth guidance to around 23...

Company Fundamentals
Bullish
1 hour ago
Nexans chosen as preferred supplier for Mallorca-Menorca power cable project to boost Balearic Islands' grid resilience.

Nexans chosen as preferred supplier for Mallorca-Menorca power cable project to boost Balearic Islands' grid resilience.

Nexans has been selected by Red Eléctrica as the preferred supplier for the Mallorca-Menorca 3 interconnection project, a key infrastructure initiative aimed at strengthening the electricity network's security and resilience in the Balearic Islands. ...

Market News
Bullish
1 hour ago
Roche posts 7% sales growth in Q3 2026, driven by strong demand for innovative medicines and diagnostics.

Roche posts 7% sales growth in Q3 2026, driven by strong demand for innovative medicines and diagnostics.

Roche reported a 7% sales increase at constant exchange rates in Q3 2026, with a 6% rise for the first nine months, fueled by high demand for key medicines like Xolair, Hemlibra, and Ocrevus. The Pharmaceuticals Division led growth, while Diagnostics...

Company Fundamentals
Bullish
1 hour ago
Nexans chosen as preferred supplier for Mallorca-Menorca power interconnection project with Red Eléctrica.

Nexans chosen as preferred supplier for Mallorca-Menorca power interconnection project with Red Eléctrica.

Nexans has been selected by Red Eléctrica as the preferred supplier for the Mallorca-Menorca 3 interconnection project, aimed at enhancing the electricity network's security and resilience in the Balearic Islands. The project includes a six-month eng...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App